Tremfya-Pso/PsA mode of Action

Name: Tremfya-Pso/PsA mode of Action
Uploaded: 2021-05-25T07:15:05.139Z
Description: Tremfya® is the first biologic indicated for the management of PsA, fully human monoclonal antibody (mAb) that selectively targets IL‑231-3

‌

Tremfya^® is the first biologic indicated for the management of PsA, fully human monoclonal antibody (mAb) that selectively targets IL‑231-3